Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CVS | WMT |
|---|---|---|
| Price | $84.96 | $108.71 |
| Change today | ▼ 1.05% | ▼ 1.65% |
| Market cap | $108.66B | $862.48B |
| Return, 3 months | -16.1% | -8.4% |
| Return, year to date | +9.6% | -1.8% |
| Return, 1 year | +14.8% | +6.7% |
| P/E (TTM) | 22.4 | 39.4 |
| P/B | 1.4 | 8.8 |
| P/E percentile vs own 5y | 69th | 56th |
| Dividend yield | 3.13% | 0.89% |
| Revenue growth (YoY, latest qtr) | +7.3% | +5.9% |
| Net profit growth (YoY) | +195.7% | -8.7% |
| Gross margin | 14.2% | 25.2% |
| Operating margin | 3.4% | 4.4% |
| Net margin | 1.2% | 3.0% |
| Return on equity | 6.2% | 23.4% |
| Analyst target vs. price | +35.4% | +18.7% |
| Analyst buy share | 100% | 90% |
| RSI (14) | 25 | 57 |
| 30-day volatility | 23.4% | 34.4% |
| Max drawdown, 1 year | -21.4% | -23.3% |
| Trend read | Strong downtrend | Leaning bullish |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.